{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-216645","form_type":"8-K","ticker":null,"cik":"0001800682","company_name":"Cano Health, Inc.","filed_at":"2023-08-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.292428+00:00","generated_at":"2026-06-11T06:24:12.094332+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cano Health names Mark Kent permanent CEO; Hernandez resigns from board","bullets":["Mark Kent appointed permanent CEO effective August 19, 2023, replacing interim designation.","Kent also elected to the Board of Directors immediately.","Dr. Marlow Hernandez resigned from the Board effective August 19, 2023.","Kent served as interim CEO since June 16, 2023, and previously as Chief Strategy Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-216645","json":"https://secwatch.observer/filing/0001193125-23-216645.json","markdown":"https://secwatch.observer/filing/0001193125-23-216645.md","text":"https://secwatch.observer/filing/0001193125-23-216645.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800682/000119312523216645/0001193125-23-216645-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800682/000119312523216645/d536673d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T06:24:12.094332+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9091d39692","claim":"Mark Kent was elected as Director at Cano Health, Inc..","evidence_excerpt":"the Board elected Mr. Kent to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800682/000119312523216645/0001193125-23-216645-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"9275ac8fed","claim":"Mark Kent was appointed as Chief Executive Officer at Cano Health, Inc..","evidence_excerpt":"the Board appointed Mark Kent, currently serving as the Company’s Interim Chief Executive Officer, as its permanent Chief Executive Officer, thereby removing the interim designation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800682/000119312523216645/0001193125-23-216645-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"a45b78bde9","claim":"Dr. Marlow Hernandez resigned as Director at Cano Health, Inc..","evidence_excerpt":"accepted Dr. Marlow Hernandez’ resignation from the Company’s Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800682/000119312523216645/0001193125-23-216645-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}